[Side effects occurring in the course of treatment of parkinsonism with L-dopa].
D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects; D003863:Depression / Q000139:chemically induced; D004064:Digestive System / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced; D009129:Muscle Tonus / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011596:Psychomotor Disorders / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D002395:Catecholamines; D004295:Dihydroxyphenylalanine
Objawy uboczne wystepujace podczas leczenia L-dopa u chorych z zespolem parkinsonowskim.